167 related articles for article (PubMed ID: 30939481)
1. Mucoepidermoid Carcinoma of the Parotid: Very Close Margins and Adjuvant Radiotherapy.
Zenga J; Yu Z; Parikh A; Chen JX; Lin DT; Emerick KS; Faquin WC; Varvares MA; Deschler DG
ORL J Otorhinolaryngol Relat Spec; 2019; 81(1):55-62. PubMed ID: 30939481
[TBL] [Abstract][Full Text] [Related]
2. Close Margins and Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Parotid Gland.
Zenga J; Parikh AS; Emerick KS; Lin DT; Faquin WC; Deschler DG
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1011-1016. PubMed ID: 29978180
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center.
Al-Mamgani A; van Rooij P; Verduijn GM; Meeuwis CA; Levendag PC
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):189-95. PubMed ID: 22330990
[TBL] [Abstract][Full Text] [Related]
4. Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation.
North L; Stadler M; Massey B; Campbell B; Shukla M; Awan M; Schultz CJ; Shreenivas A; Wong S; Graboyes E; Pipkorn P; Zenga J
Am J Otolaryngol; 2019; 40(6):102282. PubMed ID: 31519432
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features as stronger prognostic factors than histology or grade in risk stratification of primary parotid malignancies.
Walvekar RR; Filho PAA; Seethala RR; Gooding WE; Heron DE; Johnson JT; Ferris RL
Head Neck; 2011 Feb; 33(2):225-231. PubMed ID: 21298822
[TBL] [Abstract][Full Text] [Related]
6. Mucoepidermoid carcinoma of the parotid gland: the Mayo clinic experience.
Boahene DK; Olsen KD; Lewis JE; Pinheiro AD; Pankratz VS; Bagniewski SM
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):849-56. PubMed ID: 15262762
[TBL] [Abstract][Full Text] [Related]
7. Mucoepidermoid carcinoma as a secondary malignancy in pediatric sarcoma.
Rutigliano DN; Meyers P; Ghossein RA; Carlson DL; Kayton ML; Kraus D; La Quaglia MP
J Pediatr Surg; 2007 Jul; 42(7):E9-13. PubMed ID: 17618873
[TBL] [Abstract][Full Text] [Related]
8. Sclerosing mucoepidermoid carcinoma of the parotid gland: case report.
Shinhar SY
Ear Nose Throat J; 2009 Nov; 88(11):E29-31. PubMed ID: 19924654
[TBL] [Abstract][Full Text] [Related]
9. Sclerosing mucoepidermoid carcinoma of the parotid gland.
Heavner SB; Shah RB; Moyer JS
Eur Arch Otorhinolaryngol; 2006 Oct; 263(10):955-9. PubMed ID: 16858577
[TBL] [Abstract][Full Text] [Related]
10. Treatment of mucoepidermoid carcinoma of the parotid gland and successful repair of iatrogenic facial nerve paralysis.
Kutluhan A; Yurttaş V; Yuca K; Kösem M; Yakut F
Kulak Burun Bogaz Ihtis Derg; 2008; 18(1):44-8. PubMed ID: 18443403
[TBL] [Abstract][Full Text] [Related]
11. Mucoepidermoid carcinoma of the parotid gland: Twenty-year experience in treatment and outcomes.
Chan SA; Van Abel KM; Lewis JE; Routman DM; Garcia JJ; Karp EE; Price DL; Janus JR; Kasperbauer JL; Moore EJ
Head Neck; 2021 Sep; 43(9):2663-2671. PubMed ID: 33931913
[TBL] [Abstract][Full Text] [Related]
12. Presentation and outcomes of patients with clinically T1-2, N0 parotid mucoepidermoid carcinoma: The roles of elective neck dissection and adjuvant radiotherapy.
Al-Qurayshi Z; Sullivan CB; Allison DB; Buchakjian MR
Head Neck; 2022 Oct; 44(10):2151-2161. PubMed ID: 35731030
[TBL] [Abstract][Full Text] [Related]
13. Mucoepidermoid carcinoma of the parotid gland in children: A 10-year experience.
Rahbar R; Grimmer JF; Vargas SO; Robson CD; Mack JW; Perez-Atayde AR; Marcus KJ; Grier HE; Healy GB; McGill TJ
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):375-80. PubMed ID: 16618905
[TBL] [Abstract][Full Text] [Related]
14. Mucoepidermoid Carcinoma: A 23-Year Experience with Emphasis on Low-Grade Tumors with Close/Positive Margins.
Spellman J; Calzada G
Otolaryngol Head Neck Surg; 2018 May; 158(5):889-895. PubMed ID: 29313462
[TBL] [Abstract][Full Text] [Related]
15. Clinical presentation, management, and outcome of high-grade mucoepidermoid carcinoma of the parotid gland.
Emerick KS; Fabian RL; Deschler DG
Otolaryngol Head Neck Surg; 2007 May; 136(5):783-7. PubMed ID: 17478216
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors and Clinical Outcome in Parotid Gland Tumors: a Single Institution Experience from the Eastern Black Sea Region of Turkey.
Kandaz M; Soydemir G; Bahat Z; Canyilmaz E; Yoney A
Asian Pac J Cancer Prev; 2016; 17(3):1169-74. PubMed ID: 27039743
[TBL] [Abstract][Full Text] [Related]
17. Positive surgical margins in parotid malignancies: Institutional variation and survival association.
Morse E; Fujiwara RJT; Judson B; Prasad ML; Mehra S
Laryngoscope; 2019 Jan; 129(1):129-137. PubMed ID: 30194762
[TBL] [Abstract][Full Text] [Related]
18. Postoperative radiotherapy for malignant tumors of the parotid gland.
Garden AS; el-Naggar AK; Morrison WH; Callender DL; Ang KK; Peters LJ
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):79-85. PubMed ID: 9054880
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiotherapy in node-negative salivary malignancies of the parotid gland: A multi-institutional analysis.
Park JB; Wu HG; Kim JH; Lee JH; Ahn SH; Chung EJ; Eom KY; Jeong WJ; Kwon TK; Kim S; Wee CW
Radiother Oncol; 2023 Jun; 183():109554. PubMed ID: 36813174
[TBL] [Abstract][Full Text] [Related]
20. Mucoepidermoid carcinoma of the parotid gland treated by surgery and postoperative radiation therapy: clinicopathologic correlates of outcome.
Chen AM; Lau VH; Farwell DG; Luu Q; Donald PJ
Laryngoscope; 2013 Dec; 123(12):3049-55. PubMed ID: 23754320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
